Antibacterial Activity Of Barleria Prionitis

HOMESEARCH EMAILABOUT


Family Acanthaceae
Kolinta
Barleria prionitis Linn.
PORCUPINE FLOWER

Been shown to possess remarkable antimicrobial activity 4-11. However, plant-derived colorants are scantily screened for use as antimicrobial agents for protective textile finishing. Barleria prionitis L (Acanthaceae), commonly known as Vajradanti or Kundan is an erect, prickly shrub. Some species of Barleria are: B. Prionitis, B. Nutrient broth was used to test antibacterial activity of extracts.

Scientific namesCommon names
Barleria appressa (Forssk.) DeflersKokong-manok (Tag.)
Barleria coriacea Oberm.Kolinta (Tag.)
Barleria echinata St.-Lag.Korinta (Tag.)
Barleria hystrix Linn.Kulanta (Tag.)
Barleria prionitis Linn.Kuranta (Tag.)
Barleria quadrispinosa StokesBarleria (Engl.)
Barleria spicata Roxb.Common yellow nail dye plant (Engl.)
Prionitis hystrix (L.) Miq.Porcupine flower (Engl.)
Thorny nail dye (Engl.)
Barleria prionitis L. is an accepted name. The Plant List

Other vernacular names
ARABIA: Shakhad.
BENGALI: Kantajinti, Peetjhanti.
HINDI: Kala bans, Katsareya, Piabansa.
INDIA: Vajradanti, Kurantaka, Koranta, Cateserina, Katsareya,Kantajati, Muti goranta, Shemulli.
INDONESIA: Landep.
MALAYSIA: Duri landak.
MALDIVES: Dat kurandu.
SPANISH: Espinosa amarilla.
SANSKRIT: Vajradanti, Kurantaka, Koranta.
SRI LANKA: Ikshura, Ikiri, Katukarandu.

Botany
Kolinta is an erect, smooth, branched shrub, growing up to 1 to 2 meters high, with slender axillary spines. Leaves are elliptic to elliptic-ovate, 6 to 12 centimeters long, narrowed, and pointed at both ends. Flowers are yellow and axillary, with the upper ones in spikes. Bracts and calyx are green, with the outer bract usually foliaceous. Corolla is about 4 centimeters long.

Distribution
- In thickets and waste places, in and about towns, at low altitudes.
- Introduced.
- Also occurs in tropical Africa, Asia, and Malaya.

Constituents
- Large amount of neutral and acid resin soluble in light petroleum ether.

- Leaves yield alkaloids, glycosides and tannin.
- Phytochemical analysis of leaves yielded alkaloids, flavonoids, steroids, saponins, tannin, and phenolic compounds. (See study below) (18)
- An ethanolic extract yielded a new compound, balarenone (1), along with three known compounds, pi- pataline (2), lupeol (3) and 13,14-seco-stigmasta-5,14-diene-3-α -ol (4) and three different derivatives of compound (2), 7,8-epoxypipataline (5), 8- amino-7-hydroxypipataline (6) and 7,8-dibromopipataline (7). (See study below) (20)
- Phytochemical analysis of hydromethanolic extract of whole plant yielded glycosides, saponins, flavonoids, steroids, and tannins. (Maji et al., 2011). Ethanolic extract yielded balarenone, pipataline, lupeol, prioniside A, prioniside B, and prioniside C. (Ata et al., 2007; Kosmulalage et al., 2007). Aerial parts yielded glycosides viz., barlerinoside, verbascoside, shanzhiside methyl ester, 6-O-trans-p-coumaroyl-8-O-acetylshanzhiside methyl ester, barlerin, acetylbarlerin, 7-methoxydiderroside, lupulinoside. (Taneja and Tiwari, 1975; Chen et al., 1998; Singh et al., 2005; Ata et al., 2009). (23)
- Study isolated two new iridoid glycosides (1 and 2), together with known compounds barlerin (3) and verbascoside (4). (see study below) (29)

Properties
- Considered diaphoretic, diuretic, expectorant, febrifuge.
- Studies have shown antimicrobial, anthelmintic, anticataract, antifertility, antioxidant, antidiabetic, anti-arthritic, anti-inflammatory, hepatoprotective, antioxidant, analgesic properties.

Parts used
Leaves, tops, roots, juice.
Uses

Folkloric
- In the Philippines, decoction of leaves and tops used for bathing in cases of febrile catarrh.
- Whole plant used for urinary and paralytic affections, rheumatism, jaundice, hepatic obstruction and dropsy.
- In Abyssinia, used as febrifuge.
- Paste of roots is applied to boils and glandular swellings.
- In the Konkan, dried bark is given in whooping cough; for anasarca, the juice of the fresh bark with milk.
- In catarrhal afflictions of children with fever and phlegm, two teaspoons of a mixture of the juice of leaves in honey or sugar and water, twice daily.
- For rain soaked feet, juice of the leaves applied to the feet to prevent cracking and laceration.
- Juice of leaves mixed with honey applied to bleeding gums; also used as ear drops for otitis.
- In indigenous systems of medicine in India, stem, leaves and flowers are used for fever, toothaches, inflammation, gastrointestinal disorders, whooping cough. Roots used as tonic and diuretic.
- In Thailand and India, decoction of leaves and flowers used for viral fever.
- In West Bengal used by the Santals as abortifacient: 3 gm of fresh root is crushed with about 100cc of pochai (alcohol from rice) or Mahua (alcohol from flowers of Bassia latifolia, given once daily in the early morning for 3 to 5 consecutive days in induce abortion up to 3 months pregnancy.
- In Ayurveda, known as sahachara, baana, kurantaka, kuranta, koranda, korandaka, shairiya and pita-saireyaka. (23)
- In India, flowers are used internally for the treatment of migraine, internal abscesses, edema, hemoptysis, urethral discharges, seminal disorders and to reduce obesity. Leaves used for the treatment of gastric ulcers.
Others
- Dye: Study have suggest plant as a source of a natural dye. (see study below) (39)

Studies
Anti-Inflammatory / Anti-Arthritic:
Study of 'TAF' fraction from methanol-water extract of B prionitis exhibited significant anti-inflammatory activity against different animal test models and significant anti-arthritic activity in adjuvant-induced polyarthritis test in rats. (1)
Hepatoprotective: Study ethanol extract of aerial parts exhibited significant and concentration dependent hepatoprotective activity against carbon tetrachloride, galactosamine and paracetamol induced hepatotoxicity in rats. (2)
Anti-Diabetic / Leaves: Study of the alcoholic leaf extract of Barleria prionitis showed a significant decrease of blood glucose levels and glycosylated hemoglobin. (3)
Antifertility / Reduction of Spermatogenesis: Study of isolated fractions of BP root methanolic extract in rats showed a significant reduction of sperm
atogenesis, with significant reduction of sperm motility. (4)
Antifertility / Spermatogenesis Effects: Study showed root extract to exhibit interference with spermatogenesis. The antifertility effects seem to be mediated by a disturbance in testicular somatic cells functions (Leydig and Sertoli cells) resulting in the physio-morphological events of spermatogenesis. (7)
Antinociceptive / Anti-Inflammatory Activity / Flowers: Results showed the ethanolic extract of the flower of B. prionitis possess significant anti-inflammatory and antinociceptive activity.(5)
GTS (glutathione S-transferase) and Acetylcholinesterase Inhibition: Screening of crude extracts of B prionitis showed GST inhibitory activity and AChE inhibition. GTS are considered responsible for decreasing the effectiveness of anticancer / antiparasitic agents and AChE inhibitors have potential applications in the treatment of cardiac disorders and Alzheimer's disease.(6)
Antifungal / Antimicrobial / Bark: Study of methanolic extract of bark showed more potent activity against all test oral fungi (S. cerevisiae, C. albicans strains) than the standard drug Amphotericin B. Even crude extracts showed good activity against dental caries-causing oral pathogens.(8)
Anti-Inflammatory / Roots: Various root extracts were tested for anti-inflammatory activity using carrageenan-induced rat paw edema. The aqueous extract was the most active with significant dose-dependent anti-inflammatory activity.(9)
CNS Activity / Antidepressant Effect: Study evaluated the CNS activity of a 70% ethanol extract of leaves in Swiss albino mice. Results suggested B. prionitis exhibited antidepressant activity in the tested animal models.(11)
Topical Anti-Inflammatory: Study evaluated the topical anti-inflammatory activity of different species of Barleria against croton oil induced edema in female rats. The chloroform extract of B. prionitis showed the best topical activity with 88.31 per cent inhibition of ear edema.(13)
Mast Cell Stabilization and Membrane Protection: Study evaluated the membrane stabilization and mast cell protection activity of a hydroalcoholic extract of B. prionitis whole plant. Results showed dose-dependent inhibition of hypo-saline induced erythrocyte membrane hemolysis and induced mast cell degranulation . The results validate the anti-inflammatory activity and supports its traditional usage for inflammatory disorders. (14)
Anti-Diabetic / Leaves and Roots: Study evaluated the antidiabetic activity of various parts of B. prionitis using alloxan induced hyperglycemic rats. Alcoholic and aqueous extracts of leaf and root caused significant reduction in blood glucose, an effect almost equipotent to chlorpropamide.(15)
Antibacterial / Leaves: Study evaluated various extracts of B. prionitis against S. aureus, B. subtilis, P. vulgaris, K. pneumonia, E. coli and P. aeruginosa. Results showed significant activity against all tested pathogens. (16)
Antimicrobial / Bark Extracts / Oral Diseases: Study evaluated various bark extracts for antifungal activity on two Candida albicans strains and Saccharomyces cerevisiae causing oral diseases in humans and antibacterial activity against four oral bacteria, viz., S. mutans, S. aureus, Pseudomonas sp., Bacillus sp. The methanolic extract showed more potent activity against all tested oral fungi than standard drug amphotericin B. The methanolic extract was also most effective against all four oral bacteria.(17)
Antihypertensive Activity / Leaves: Study evaluated the antihypertensive activity of a methanolic extract of leaves using DOCA salt induced antihypertensive model. Results showed significant antihypertensive effect. Phytochemical analysis yielded alkaloids, flavonoids, steroids, saponins, tannin and phenolic compounds.(18)
Nootropic Activity / Memory Function / Leaves: Study evaluated a leaf extract for effects on cognitive dysfunction and influence on brain cholinergic system in experimental rats. Results showed the leaf extract enhances memory function possibly mediated through the brain cholinergic system. (19)
Antibacterial / Glutathione S-Transferase and AChE Inhibitory Activity: Study yielded a new compound, balarenone (1) along with three known compounds 4, 5 and 6, three derivatives of compound 2 (5,6 and 7). Compounds 1,2, and 4 exhibited antibacterial activity against B. cereus and P. aeruginosa. Compounds 1-4 showed activity against GST and AChE. (See constituents above) (20)
Immunomodulatory Activity / Aerial Parts: Study investigated in vivo and in vitro immunomodulatory activities of the iridoids fractions of B. prionitis aerial parts. Results showed potent immunostimulatory activity, stimulating both the specific and non-specific immune mechanisms. (21)
Anti-Arthritic Activity / Leaves: Study investigated the anti-arthritic potential of ethyl acetate fractions of chloroform extract of leaves of B. prionitis against formaldehyde-induced acute non- immunological and Freund's Complete Adjuvant-induced chronic immunological arthritis in rats. Results showed dose-dependent and significant inhibition of edema in both acute and chronic models. (24)
Anticataract Potential / Leaves: Study evaluated the anticataract potential of B. prionitis using Selenite and Galactose induced cataract models. Results showed oral administration of Barleria prionitis significantly delayed the onset and progression of cataract in Selenite as well as Galactose induced cataract. BP reverses cataract parameters by virtue of its antioxidant potential. (25)
Antioxidant Potential / Leaf and Stem: Study investigated the antioxidant potential of different extracts of BP leaf and stem, measured against DPPH as compared to standard ascorbic acid and BHA. Methanolic extracts of both leaf and stem should highest IC50 values of 63.41±0.32, 81.69±0.40 respectively. Antioxidant activity was attributed to phenolic contents. (26)
Gastroprotective / Anti-Ulcer / Leaves: Study evaluated the gastroprotective activity of leaf extracts using experimental in-vivo models. The chloroform extract and ethyl acetate fraction prevented gastric ulceration caused by indomethacin. Also, the EA fraction inhibited gastric secretion in pylorus ligated rats. (27)
• Effect on Oral Health as Mouthwash: Study evaluated the efficacy of Barleria prionitis extract mouthwash in comparison with gold standard chlorhexidine (CHX) mouthwash on oral health. Results showed CHX and B. prionitis were statistically equally effective against dental plaque. Results suggest antimicrobial potential and supports its folklore use as preventive remedy against oral microbial diseases. (28)
• Iridioids / Anti-Viral: Study isolated two new iridoid glycosides (1 and 2), together with known compounds barlerin (3) and verbascoside (4). A 3:1 mixture of 1 and 2 were shown to have potent in vitro activity against respiratory syncytial virus with EC50 2.46 µg/ml and IC50 of 42.2 µg/ml. (29)
• Silver and Gold Nanoparticles / Catalytic Potential / Leaves: Study reports on the rapid, efficient, eco-friendly synthesis of silver and gold nanoparticles using Barleria prionitis leaf extract. Both Ag and Au nanoparticles exhibited efficient catalytic reduction of o-nitrophenol to o-aminophenol. (30)
• Gastroprotective in Various Ulcer Models / Antioxidant / Leaves: Study evaluated the gastroprotective effect and in vivo antioxidant potential of a standardized iridoid fraction from B. prionitis leaves against different gastric ulcer methods in rats. The extract showed a dose dependent ulcer protective effect in pylorus ligation, aspirin, cold restrained stress and ethanol induced ulcer models. Treatment showed a decreased in acid-pepsin secretion and enhanced mucin and mucosal glycoproteins. The BPE reduced the ulcer index with a significant decrease in LPO and an increase in CAR activity in the CRS-induced model. (31)
• Antioxidant: Study evaluated the antioxidant activity of various fractions (hexane, chloroform, ethyl acetate, and butanol) of 90% methanolic extract using DPPH assay and ascorbic acid as standard. The ethyl acetate soluble fractions showed maximum activity followed by butanol, chloroform, methanol, and hexane fractions. (32)
• Antibacterial / Aerial Parts: Study evaluated the antimicrobial effects of B. prionitis ethanol extract of leaves against five pathogenic bacteria. Best results were seen against P. aeruginosa, followed by B. thruengenesis, C. diphtheria, S. typhi, and C. pneumonia. Phytochemical screening of leaves yielded alkaloids, flavanoids, saponins, and tannins. (33)
• Antimicrobial / TNF-Alpha Inhibitory Activity: Study evaluated the antimicrobial activity of aqueous and ethanolic leaf extracts of Barleria prionitis and A. grandiflora in the treatment of oral ailments such as gingivitis. Both extracts showed significant antimicrobial potency. The cytokine level significantly increase by Streptococcus mutans was significantly reduced in a dose dependent manner by ethanolic extracts in S. mutans stimulated HGF cells. Both ethanolic extracts EBG and EBP showed 65.32 ± 1.087 and 75.0425 ± 1.268 ∞ inhibition of TNF-a at tested concentrations. (34)
• Antimicrobial / Common Respiratory Tract Infections / Aerial Parts: Study evaluated the antimicrobial potential of B. prionitis aerial parts against bacterial and fungal infections. Maximum inhibition zone was found against S. pneumonia (19.40 ± 0.64 mm), followed by S. aureus, P. aeruginosa, S. pyogenes, H. influenza, and Candida albicans. (36)
• Antipyretic / Leaves: Study of a methanolic leaf extract of Barleria prionitis in albino rats using Brewer's yeast induced pyrexia method showed significant antipyretic activity. Paracetamol was used as standard. (37)
• Synergistic Composition with B. prionitis / Hepatoprotective / Immunomodulatory: Invention presents a synergistic composition of bioactive fractions consisting of iridoid glucosides, acetyl barlerin, and shanzhiside methyl ester isolated from Barleria prionitis along with the process of isolating the bioactive fraction. The invention relates to use for treatment of mammals for hepatotoxicity, stress, and immunodeficiency with synergistic bioactive composition. (38)
• Natural Dye / Antifungal / Aerial Biomass: Study the natural dye extracted from aerial parts of Barleria prionitis and different kinds of textile fabrics dyed with the natural dye for antifungal activity against standard strains of Aspergillus flavus, A. niger, and A. parasiticus, Fusarium moniliforme and Penicillium canescens. The highest antifungal growth reduction was noted at 500 µg/ml concentration of the natural dye. MIC ranged between 22.50-23.50 µg/mL. Dyed silk, wool, and cotton fabrics showed remarkable antifungal efficacy against all test fungi. Results suggest B. prionitis as a potential source of natural dye with functional properties in providing a protective finishing for various types of textile fibers. (39)
• Anti-Parkinsonism: Study investigated the aqueous extract of Barleria prionitis. for in vivo antioxidant and anti-parkinson properties and neurotransmitter level using MPTP induced parkinson and Rotenone induced Parkinson models. Levodopa was used as standard for both models. Results showed significant anti-parkinsonism activity in MPTP and rotenone model in mouse and rats, respectively. Mode of action was attributed to decreased lipid peroxidation due to presence of flavonoids, polyphenols and glycosides. Extract treated groups woe better results compared with MPTP and Rotenone-induced group and standard L-dopa treated group. (40)
• Platinum and Palladium Nanoparticles / Anticancer / Leaves: Study reports on the synthesis of platinum nanoparticles (PtNPs) and palladium nanoparticles (PdNPs) using Barleria prionitis leaf extract. Both PtNPs and PdNPs were tested for anticancer activity against human breast adenocarcinoma (MCF-7) cell lines and showed reduced viability up to 60.08 ± 2.4% and 57.22 ± 1.68%, respectively. (41)
• Anthelmintic / Fruit: Study evaluated the anthelmintic activity of aqueous and ethanolic extracts of whole plant of B. prionitis against Pheretima posthuma in measures of time of paralysis and time of death. Albendazole was used as standard. Results showed both extracts significantly caused paralysis (p<0.01) in worms in lower doses (50, 75, and 100 mg/ml) and caused death of worms at higher dose of 100 mg/ml compared to standard drug. (42)

Availability
Wild-crafted.


doi: 10.4103/0253-7613.64493
PMID: 20711368
This article has been cited by other articles in PMC.

Abstract

Objectives:

To study the antidiabetic activity of Barleria prionitis Linn in normal and alloxan-induced diabetic rats.

Materials and Methods:

Alcoholic extract of leaf and root of B. prionitis was tested for their antidiabetic activity. Albino rats were divided into six groups of six animals each. In three groups, diabetes was induced using alloxan monohydrate (150 mg/kg b.w., i.p.) and all the rats were given different treatments consisting of vehicle, alcoholic extract of leaves, and alcoholic extract roots of B. prionitis Linn (200 mg/kg) for 14 days. The same treatment was given to the other three groups, comprising non-diabetic (normal) animals. Blood glucose level, glycosylated hemoglobin, liver glycogen, serum insulin, and body weight were estimated in normal and alloxan-induced diabetic rats, before and 2 weeks after administration of drugs.

Results:

Animals treated with the alcoholic extract of leaves of B. prionitis Linn showed a significant decrease in blood glucose level (P<0.01) and glycosylated hemoglobin (P<0.01). A significant increase was observed in serum insulin level (P<0.01) and liver glycogen level (P<0.05), whereas the decrease in the body weight was arrested by administration of leaf extract to the animals. The alcoholic extract of roots showed a moderate but non-significant antidiabetic activity in experimental animals.

Conclusion:

The study reveals that the alcoholic leaf extract of B. prionitis could be added in the list of herbal preparations beneficial in diabetes mellitus.

Keywords: Barleria prionitis, alloxan monohydrate, alcoholic extract

Introduction

Diabetes mellitus is the most important non-infective epidemic to hit the globe in the present millennium. By the year 2025, India shall have the maximum number of diabetics in the world making it, the “Diabetic capital of the world.”[1] Despite the great strides, made in understanding and management of diabetes, the disease and disease-related complications are increasing unabated due to multiple defects, in its pathophysiology.[] Parallel, to this, the holistic approach of herbs has accelerated the global efforts to harness and harvest medicinal plants having multiple beneficial effects.[3] Some of them have been evaluated and active principles isolated; however, the search for novel antidiabetic drugs continues.[4]

Barleria prionitis Linn (Acanthaceae) is a well-known plant in Ayurveda. It is distributed throughout India, Ceylon, and South Asia.[5] The plant is said to be rich in potassium and valued as diuretic.[] Flavonoids, iridoid glucosides, and fatty acids have also been reported.[7‐9] The extract of plant rich in iridoid glycosides is a potent hepatoprotective agent[] and useful in respiratory infections,[] whooping cough, and tuberculosis.[11] The juice of leaves is useful in fungal infections,[12] wound healing, bleeding teeth, toothache, and joint pain.[13,14] The roots are used in fever and glandular swelling and have been shown to 100% antifertility activity.[] The plant has many uses but the antidiabetic potential of the plant is yet to be explored, so B. prionitis was selected for the present study.

Materials and Methods

Plant Material and Extract Preparation

Fresh leaves and roots of healthy mature plants of B. prionitis after authentification and verification (RUBL20108) were collected from the medicinal garden of Lal Bahadur Shastri College of Pharmacy, Jaipur, where it grows. The leaves and roots were dried under shade, coarsely powdered and were packed separately in airtight containers.

Alcoholic Extract

The dried plant material was coarsely powdered. The powdered mass of each part was defatted with petroleum ether (60-80°C) followed by extraction with alcohol (95% v/v) and water. The yield was found 2.16% in roots and16.64% in leaves.

The dried alcoholic extract was formulated as suspension using distilled water and the strength of the suspension adjusted according to the dose administered (i.e. 200 mg/kg).

Both the alcoholic extract of roots and leaves drug were administered orally twice a day, for 2 weeks, in a dose of 200 mg/kg body weight, with the help of a gastric catheter.

Preliminary Phytochemical Screening

The chromatographic analysis of the root and leaf extract did not show the presence of the alkaloids as per monograph in the 3rd volume of Ayurvedic pharmacopoeia. Beta-sitosterol, saponins, tannins, and flavonoids were found present in both the root and the leaf alcoholic extract.[16]

Animals

Adult albino rats of either sex weighing between 180 and 200 g were acclimatized for a period of 7 days at room temperature (25±2°C) and 50±15% relative humidity. They were housed in a standard cage and maintained on standard pellets and water at libitum. The animals described as “fasted” were deprived of food for 18 h, but had free access to water. Teamspeak 3 spam bot meaning. The study was carried out in the Toxicology Lab of Zoology Department, University of Rajasthan, and the study protocol was approved by the Institutional Ethics Committee.

Ipsw installer

Toxicity Studies

Adult albino rats were used for this study. The alcoholic extract of roots and leaves of B. prionitis Linn at different dose levels i.e. 1, 1.5, 2, 2.5 g/kg body weight was administered orally. The control group received distilled water. The animals were observed for 14 days, for mortality and general behavior. No death was observed upto the end of the study. The test samples were found safe up to 2.5 g/kg.

Induction of Diabetes

A single dose (150 mg/kg b.w., i.p.) of alloxan monohydrate (Sigma Ltd, USA) dissolved in normal saline was used for induction of Type II diabetes in rats after overnight fasting. After 1 h of alloxan administration, the animals were fed standard pellets and water ad libitum. The animals were stabilized for a week and animals showing blood glucose level (estimated by GOD-POD method) more than 200 mg/dl were selected for the study.

Experimental Design

The fasted rats were divided into six groups of six animals each (three group of normal animals and three groups for induction of diabetes). No standard of comparison was used.

Group I- Served as normal control rats and received distilled water .

Group II- Diabetic rats served as diabetic control and received distilled water.

Group III- Diabetic rats received alcoholic extract of leaves (200 mg/kg b.w.) using an intra gastric tube for 2 weeks.

Group IV- Normal rats received alcoholic extract of leaves (200 mg/kg b.w.) using an intra gastric tube for 2 weeks.

Group V- Diabetic rats received alcoholic extract of roots (200 mg/kg b.w.) using an intra gastric tube for 2 weeks.

GroupVI- Normal rats received alcoholic extract of roots (200 mg/kg b.w.) using an intra gastric tube for 2 weeks.

The drug treatment was carried out every day morning (200 mg/kg b.w.) and evening (200 mg/kg b.w.) with the help of intragastric tube for 2 weeks.

After 2 weeks, body weights were determined and the animals were sacrificed under the influence of anesthetic ether. The blood was collected by heart puncture and the liver was excised and chilled in ice cold 0.9% sodium chloride.

Methods

The blood sample withdrawn from the sacrificed animals was centrifuged at 3000 rpm for 10 min.[17] Blood glucose,[] glycosylated hemoglobin,[] and serum insulin (RIA using a kit from BARC, Mumbai, India Ltd) were estimated on the 15th day. The excised liver tissue was processed and liver glycogen was estimated.[]

Statistical Analysis

All the values were expressed as mean ± SEM. The data obtained through careful observation were analyzed using Student's t-test. Wherever required ANOVA followed by Dunnets multiple 't'-test was used. A “P” Value of less than 0.05% was considered statistically significant.

Results

Effect on Blood Glucose

Analysis of data shows a decrease in the blood glucose level on treatment with the alcoholic extract of leaves and roots (200 mg/kg, orally for 2 weeks). The alcoholic leaf extract exhibited a statistically significant decrease (P<0.01) in the blood glucose level when comparison was done with the diabetic control group and between before and after treatment. But the decrease with the alcoholic root extract was statistically non-significant [Figures [Figures11 and and2].2]. Both the test drugs i.e. alcoholic extract of leaves and roots did not affect the blood glucose in normal rats [Figure 3].

Effect of leaf and root extract of Barleria prionitis Linn. On blood glucose level in alloxan induced diabetic rats.

Efeect of leaf and root extract of Barleria prionitis Linn. On blood glucose level in alloxan induced diabetic rats

Effect of leaf and root extract of Barleria prionitis linn. On blood glucose level in normal rats

Effect on Serum Insulin Level

Insulin level was found to be decreased in the alloxan-induced diabetic rats. On administration of both leaf extract (P<0.01) and root extract (P<0.05), there was an increase in serum insulin level which was statistically significant [Table 1].

Table 1

Effect of alcoholic extract of leaves and roots of Barleria prionitis Linn. on serum insulin, liver glycogen, and glycosylated hemoglobin

ParametersNormal controlDiabetic controlRoot treated% ChangeLeaf treated% Change
Serum insulin43.40 ± 2.7120.00 ± 1.5326.00 ± 2.61*↑30.00@46.30 ± 4.54**↑130.00@
Liver glycogen4.20 ± 0.271.81 ± 0.172.65 ± 0.62↑46.40@3.56 ± 0.64*↑96.68@
Glycosylated hemoglobin6.00 ± 0.8109.00 ± 0.64**08.00 ± 0.89↓11.00@7.00 ± 0.71**↓22.00@

Each value represents the mean ± SEM of six observations, Student's paired 't'-test :

**P < 0.01
- Increase

Effect on Glycosylated Hemoglobin

A statistically significant increase (P<0.01) was seen in the level of the glycosylated hemoglobin in the diabetic control group. The alcoholic leaf extract significantly decreased (P<0.01) the glycosylated hemoglobin level, but a moderate and non-significant decrease was seen with alcoholic root extract [Table 1].

Effect on Liver Glycogen

Depletion of liver glycogen content was seen in the diabetic control group. A significant increase (P<0.05) in the glycogen content of liver was observed after administration of alcoholic leaf extract, but increase with alcoholic root extract was statistically not significant [Table 1].

Effect on Body Weight

Body weight of alloxan-induced diabetic rat was found to be statistically less compared to the normal rats at basal level (before treatment) (P<0.01). Weight gain was not observed after the treatment with either of the test drugs, but the decrease in body weight in alcoholic leaf extract group was found to be very negligible, however statistically non-significant [Figure 4].

Effect of leaf and root extract of Barleria prionitis linn. On body weight in alloxan induced diabetic rats.

Discussion

The study reports the antidiabetic activity of alcoholic extract of leaves of B. prionitis Linn, which is a well-known herb in Ayurveda. Phytochemical analysis of B. prionitis shows the presence of sterols, saponins, tannins, and flavonoids. Flavonoids, sterols/triterpenoids, tannins, and phenolics are known bioactive antidiabetic principles.[,3,] Flavonoids are also known to regenerate the damaged beta cells in the alloxan diabetic rats.[22]

In the present study, alloxan was used as a diabetogen. It induces diabetes by destroying β-cells of the pancreas partially, through production of reactive oxygen species.[] Alcoholic extract of leaves and roots were assessed for their antidiabetic activity. The alcoholic leaf extract exhibited a significant decrease in the blood glucose level in alloxan-induced diabetic animals. A non-significant decrease was seen with the alcoholic root extract. But both the treatments did not produce hypoglycemia in normal rats, which is a therapeutic advantage.

Insulin level was found decreased in alloxan-induced diabetic rats. Reversal of this effect was seen on treatment by the leaf extract This may be indicative of regeneration of the islet cells more by the leaf extract, and possibly, attenuation of the alloxan initiated degenerative changes more prominently in the leaf extract-treated group as compared to the root extract-treated group. The same treatment, however, did not increase the serum insulin level in normoglycemic rats, so it can be concluded that the extract has the potential to enhance the glucose-dependent insulin release from the pancreatic beta cells and thereby decrease the blood glucose level only in alloxan-induced diabetic rats. The action of extract is very similar to biguanides, which are also termed as “Euglycemics.” Biguanides brings the elevated blood sugar level to its normal value and do not produce hypoglycemia. Biguanides promote peripheral uptake and utilization of blood glucose and they also exhibit a favorable effect on lipid profile i.e. a decrease in the TGs.[] In a study conducted, B. prionitis has been reported as a potent hepatoprotective, showing a highly significant decrease in TGs.[] This suggests that the mechanism of studied herb is similar to that of biguanides.

In diabetes, glycogen content decreases due to enhanced glycogenolysis and the normal capacity of the liver to synthesize glycogen is impaired, which is due to insulin deficiency.[] The liver glycogen was found depleted in the diabetic control group. A significant increase in the liver glycogen level on administration of alcoholic leaf extract was observed which may be due to an increase in the insulin level by it. Reversal of the depletion indicates attenuation of severity of diabetes and can be considered as an index of the presence of antidiabetic activity in the test drug.

Protein can universally bind non-enzymatically with glucose or other sugars present in the vicinity. The degree of glycation is directly proportional to the concentration of the sugar present in the surrounding medium. Therefore, estimation of glycosylated hemoglobin (HbA1c) gives an accurate reflection of mean plasma glucose concentration over this period and correlates best with the degree of the glycemia.[] A change in HbA1c of 1% would reflect a blood glucose alteration of about 30 mg%. A significant decrease with leaf extract (P<0.01) was observed in the treated rats as compared to alloxan-induced diabetic rats. On treatment with roots, the decrease was moderate. This is indicative of a better glycemic control for a longer period by the leaf sample.

A significant reduction in the body weight was observed in the alloxan-induced diabetic rats. The decrease in the weight in diabetes is due to continuous excretion of glucose and decrease in peripheral uptake of glucose and glycogen synthesis.[] The decrease in weight was arrested on administration of alcoholic leaf extract to a greater extent as compared to root extract. All the above observations suggest that the test drug i.e. alcoholic leaf extract can be a promising antidiabetic.

Conclusion

Studies revealed that alcoholic leaf extract of B. prionitis can be considered as an important addition to the therapeutic armamentarium for the treatment of diabetes. Further studies can be undertaken at the cellular and molecular level, which may further elucidate its mechanism in detail.

Acknowledgments

The authors are thankful to Emeritus Professor Dr. V N Sharma and Professor Rakesh Gupta for providing necessary guidance.

Footnotes

Source of Support: Nil

Conflict of Interest: None declared.

References

1. Hillary K, Ronald EA, William HH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care. 1998;21:141–3.[Google Scholar]
2. Ivorra MD, Payá M, Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol. 1989;27:243–75. [PubMed] [Google Scholar]
3. Kameswara Rao, Giri, R, Kesavulu MM, Apparao Herbal medicine in the treatment of diabetes mellitus. Manphar Vaidhya Patrika. 1997;1:33–5.[Google Scholar]
4. Nagarajan S, Jain HC, Aulakh GS. Indigenous plants used in the control of Diabetes, Publication and Information Directorate. New Delhi: CSIR; 1987. p. 586. [Google Scholar]
5. Burkill HM. The useful plants of West Tropical Africa. UK: Royal Botanic Garden Kew; 1985. p. 960. [Google Scholar]
6. Gujral ML, Saxena PN, Mishra SS. An experimental study of the comparative activity of indigenous diuretics. J Indian Med Assoc. 1995;25:49. [PubMed] [Google Scholar]
7. Nagarjuna S, Barnabas CGG. Antimicrobial activity of Flavanoids of Plant extracts. Department of Chemistry, Bharatidasan University T.N : 1986. [Google Scholar]
8. Singh B, Chandan BK, Prabhakar A, Taneja SC, Singh J, Qazi GN. Chemistry and hepatoprotective activity of an active fraction from Barleria prionitis Linn.in experimental animals. Phytother Res. 2005;18:391–404. [PubMed] [Google Scholar]
9. Gupta HM, Saxena VK. Chemical examination of the glyceride contents of the Roots of B.Prionitis Linn: Bulletin of Medico-Ethno Botanical Research. New Delhi: CCRAS; 1986. pp. 178–83. [Google Scholar]
10. Chen JL, Blanc P, Stoddart CA, Bogan M, Rozhon EJ, Parkinson N, et al. New iridoids from the medicinal plant Barleria prionitis with potent activity against respiratory syncytial virus. J Nat Prod. 1998;612:1295–7. [PubMed] [Google Scholar]
11. Oomachan, MM Ethno-botanical and conservation aspects of Medicinal Plants of Madhya Pradesh. In J of Pure and Appli Sci. 1991;6:39.[Google Scholar]
12. Panwar HS, Nauriyal MM, Joshi HC. In vitro screening of certain indigenous plants for their antimycotic activity. Veterinary Res Bull. 1979;2:164–7.[Google Scholar]
13. Parrotta, JA . Healing plants of Peninsular India. Wellington, UK & New York: CABI Publishing; 2001. p. 917. [Google Scholar]
14. Kakrani HN, Saliya AK. Traditional treatment through herbs in Kutch district, Gujarat State, India Part-II: Analgesic, anti-inflammatory, antirheumatic, anti-arthritic plants Fitoterapia. 1994;5:427.[Google Scholar]
15. Gupta RS, Kumar P, Dixit VP, Dobhal MP. Antifertility studies of the root extract of the Barleria prionitis Linn in male albino rats with special reference to testicular cell population dynamics. J Ethnopharmacol. 2000;70:111–7. [PubMed] [Google Scholar]
16. Pharmacopoeial standards for Ayurvedic Formulations Central Council for Research in Ayurveda and Siddha, Ministry of Health and Family Welfare, Government of India. 1987:41–60.[Google Scholar]
17. Basu V, Gangadevi T, Subramaniam A. Antihypoglycemic activity of cassia kleini leaf extract in glucose fed normal rats and alloxan induced diabetic rats. Indian J pharmacol. 2002;34:209–15.[Google Scholar]
18. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol. 1969;22:246.[PMC free article] [PubMed] [Google Scholar]
19. Parker KM, England JD, Da Costa J, Hess RL, Goldstein DE. Improved colorimetric assay for glycosylated hemoglobin. Clin Chem. 1981;27:669–72. [PubMed] [Google Scholar]
20. Seifter S, Dayton S, Novice B, Muntwyler E. The estimation of glycogen with anthrone reagent. Arch Biochem. 1950;25:191–200. [PubMed] [Google Scholar]
21. Atta-Ur-Rahman, Zaman K. Medicinal plants with hypoglycemic activity. J Ethnopharmacol. 1989;26:1–55. [PubMed] [Google Scholar]
22. Chakkvarthy BK, Gupta S, Gambir SS, Gode KD. Pancreatic Beta cell Regeneration.A novel antidiabetic mechanism of Pterocarpus marsupium Roxb. Indian J Pharma. 1980;12:123–7.[Google Scholar]
23. Malaisse WJ. Alloxan toxicity to the pancreatic B-cell: A new hypothesis. Biochem Pharmacol. 1982;31:3527–34. [PubMed] [Google Scholar]
24. Dagogo-Jack S, Santiago JV. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med. 1997;157:1802–17. [PubMed] [Google Scholar]
25. Yki-Järvinen H, Taskinen MR. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes. 1988;37:1271–8. [PubMed] [Google Scholar]
26. Danze PM, Tarjoman A, Rousseaux J, Fossati P, Dautrevaux M. Evidence for an increased glycation of IgG in diabetic patients. Clin Chim Acta. 1987;166:143–53. [PubMed] [Google Scholar]
27. Defronzo RA, Bonadonna RC, Ferrannini I. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview. Diabetologia. 1992;35:389–97. [PubMed] [Google Scholar]
Articles from Indian Journal of Pharmacology are provided here courtesy of Wolters Kluwer -- Medknow Publications